Breast Carcinoma by Gene Expression Profile

Breast Carcinoma by Gene Expression Profile — Trials · CancerIndex

Clinical trials

Registered studies

1,299 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 537
Recruiting: 295
Ph III recruiting: 37
Growth YoY: +3.8%
Industry share: 28%
Top sponsor: Fudan University
Termination share: 46%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (217)

clinicaltrialsPublishedShowing 1–50 of 97 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06799065	First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer	recruiting	Phase 1 / Phase 2	218	Accent TherapeuticsINDUSTRY	1	Sep 29, 2026	clinicaltrials
NCT06586957	A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors	recruiting	Phase 1	238	NiKang Therapeutics, Inc.INDUSTRY	1	Sep 28, 2026